Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Total Debt came in at $10.53 million for the quarter ended Dec 31, 2025, down 12.5% from $12.03 million a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Total Debt (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Total Debt was $10.39 million, down 13.6% from the prior year.

  • Going back by year, Total Debt was $12.03 million in the year ended Dec 31, 2024 (-5.4%), $12.71 million in the year ended Dec 31, 2023 and -$33,511 in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 70.82 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 26.25 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 63.19 Bn
10 Zhengye Biotechnology Holding 69.19 Mn 65.60 Mn - 10.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.67 Mn
Jun 30, 2025 11.96 Mn
Dec 31, 2024 11.84 Mn
Dec 31, 2023 12.64 Mn
API Access

Zhengye Biotechnology Holding Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ZYBT&period=max&api_key=YOUR_API_KEY